Medicine & Life Sciences
Pharmacokinetics
100%
Hepatocytes
91%
Cytochrome P-450 CYP3A
86%
Lamotrigine
82%
Tacrolimus
80%
carbovir
72%
Artificial Liver
68%
Transplant Recipients
61%
Phenytoin
53%
Biological Availability
52%
Liver Microsomes
47%
Kidney
45%
Felbamate
43%
Glucuronosyltransferase
42%
Carbamazepine
42%
Pharmaceutical Preparations
41%
6-aminocarbovir
41%
Glucuronides
40%
HIV
39%
Swine
38%
In Vitro Techniques
33%
Epilepsy
33%
Indinavir
33%
Enzymes
33%
Cytochrome P-450 Enzyme System
32%
Liver
32%
High Pressure Liquid Chromatography
29%
African Americans
28%
indomethacin phenethylamide
27%
Prodrugs
27%
Valproic Acid
25%
Midazolam
23%
Allografts
22%
Anticonvulsants
22%
Nucleosides
22%
Cannabidiol
22%
Lidocaine
21%
Collagen
21%
Drug Interactions
20%
Cytochrome P-450 CYP2C9
20%
Liquid Chromatography
20%
bilirubin glucuronoside glucuronosyltransferase
20%
Gels
20%
Transgenic Mice
19%
Cyclooxygenase 2 Inhibitors
19%
Genotype
19%
zolazepam drug combination tiletamine
18%
Uridine Diphosphate
17%
Acridines
17%
Chemical Compounds
Pharmacological Metabolism
76%
Lamotrigine
50%
(-)-Carbovir
48%
Pharmacokinetics
42%
Dose
42%
Metabolite
41%
Plasma
37%
Clearance
30%
Midazolam
29%
Lidocaine
29%
Metabolic
28%
Prodrug
27%
Cytochrome P450
23%
Bioavailability
22%
Drug
20%
4-Methylumbelliferone
19%
Collagen Gel
19%
Radioactivity
17%
Carbovir
16%
Clonazepam
16%
Cyclooxygenase 2 Inhibitor
16%
Protein
16%
Reaction Half Life
16%
Liquid Chromatography
16%
Anticonvulsant
15%
Warfarin
14%
Bioreactors
13%
Uridine
13%
Nucleoside
13%
Bilirubin
12%
Valproic Acid
11%
Collagen
11%
Intraportal
10%
Biosynthesis
10%
Cytochrome
10%
3-Hydroxylidocaine
10%
Thiotepa
9%
Morphine
9%
Busulfan
9%
EC 3.5.4.4 (Adenosine Deaminase) Inhibitor
9%
Ketoconazole
9%
Gas Chromatography Mass Spectrometry (GCMS)
9%
carbamazepine-10,11-epoxide
9%
Nelfinavir
9%
Topiramate
9%
Saquinavir
9%
Tissue Culture Medium
9%
Indinavir
8%
Liquid
8%
Cell Death
8%